Keating Financial Advisory Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$964 Sell
161
-57
-26% -$429 ﹤0.01% 2102
2025
Q4
$1.56K Buy
+218
New +$1.72K ﹤0.01% 1660

Other funds holding OGN

Keating Financial Advisory Services's OGN Position: Q1 2026 in Review

Keating Financial Advisory Services reduced its Organon & Co (OGN) stake by 26% in Q1 2026, selling an estimated $429 and leaving 161 shares worth $964. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Keating Financial Advisory Services first reported a position in OGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.56K in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Keating Financial Advisory Services held 161 shares of Organon & Co worth $964 as of Q1 2026.
  • Keating Financial Advisory Services sold 57 Organon & Co shares in Q1 2026, an estimated $429.
  • Organon & Co made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q1 2026, its #2102 holding.
  • Keating Financial Advisory Services first reported a position in Organon & Co in Q4 2025 and has held it in 2 quarters since.
  • Keating Financial Advisory Services's Organon & Co position peaked at $1.56K in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Keating Financial Advisory Services's 13F filing for Q1 2026, filed 15 May 2026.